Evidence map›Paper›PMID 31564817›Full record

ArticleClinical ophthalmology (Auckland, N.Z.)2019

Comorbid hepatitis C does not modulate prevalence or severity of diabetic retinopathy.

Lisa R Koenig, Russell Rosenblatt, Rahil M Patel, Yiyuan Wu, Thanos D Papakostas, Anton Orlin, Robison V Paul Chan, Szilard Kiss, Donald J D'Amico, Sonal Kumar and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical ophthalmology (Auckland, N.Z.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Lisa R KoenigDepartment of Ophthalmology, Weill Cornell Medicine, New York, NY, USA.ORCID 0000-0002-9458-5999
Russell RosenblattDepartment of Medicine, Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, NY, USA.
Rahil M PatelColumbia College of Columbia University in the City of New York, New York, NY, USA.
Yiyuan WuDivision of Biostatistics and Epidemiology, Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, NY, USA.
Thanos D PapakostasDepartment of Ophthalmology, Weill Cornell Medicine, New York, NY, USA.
Anton OrlinDepartment of Ophthalmology, Weill Cornell Medicine, New York, NY, USA.
Robison V Paul ChanDepartment of Ophthalmology, Weill Cornell Medicine, New York, NY, USA.
Szilard KissDepartment of Ophthalmology, Weill Cornell Medicine, New York, NY, USA.
Donald J D'AmicoDepartment of Ophthalmology, Weill Cornell Medicine, New York, NY, USA.
Sonal KumarDepartment of Medicine, Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, NY, USA.
Mrinali P GuptaDepartment of Ophthalmology, Weill Cornell Medicine, New York, NY, USA.
Cornell University · USColumbia University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThere are limited and conflicting data regarding the impact of comorbid hepatitis C virus (HCV) infection on diabetic retinopathy (DR). This study sought to compare the prevalence and severity of DR among patients with diabetes mellitus (DM) with and without HCV. PATIENTS AND

methodsThis was a retrospective, case-control study of patients with DM comparing 120 patients with comorbid HCV and 120 age-matched controls. DR prevalence and several measures of severity were compared between groups. Subgroup analyses were performed among HCV patients with cirrhosis, comorbid HIV, or history of treatment with interferon. Statistical analysis for between-group comparisons utilized both univariate and multivariate analyses.

resultsCases and controls exhibited similar baseline characteristics: average hemoglobin A1c, DM duration, and age (

conclusionIn this study, comorbid HCV did not modulate the prevalence or severity of DR among patients with DM. These findings may inform clinical monitoring among HCV-positive diabetics undergoing ophthalmic evaluation.

Indexed as

cirrhosisdiabetes mellitushepatitisretinopathy

Identifiers

PMID31564817
PMCPMC6731984
OpenAlexW2971367160

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.